How Cipro penetrates the prostate barrier, risks of long-term courses, chronical prostatitis success rates, and safe alternatives.
How Cipro penetrates the prostate barrier, risks of long-term courses, chronical prostatitis success rates, and safe alternatives.
Why Cipro is no longer recommended as first-line for uncomplicated UTIs, risk-benefit comparison with other antibiotics, and resistance trends.